We observed some minor but significant decreases in aCL IgG and anti-β2-GPI IgG after COVID-19 infection and/or vaccination and some minor but significant increases in aCL IgM and anti-b2-GPI IgM in patients who were both vaccinated against and infected with COVID-19. This evidence concerns the gene ACLY and COVID-19.